Mostrar el registro sencillo del ítem
dc.contributor.author
Ridruejo, Ezequiel
dc.contributor.author
Mendizabal, Manuel
dc.contributor.author
Silva, Marcelo O.
dc.date.available
2019-10-18T19:17:42Z
dc.date.issued
2018-04
dc.identifier.citation
Ridruejo, Ezequiel; Mendizabal, Manuel; Silva, Marcelo O.; Rationale for treating hepatitis C virus infection in patients with mild to moderate chronic kidney disease; Wiley Blackwell Publishing, Inc; Hemodialysis International; 22; 4-2018; S97-S103
dc.identifier.issn
1492-7535
dc.identifier.uri
http://hdl.handle.net/11336/86460
dc.description.abstract
Hepatitis C virus infection (HCV) is highly prevalent in patients with chronic kidney disease (CKD) and kidney transplant recipients. Little information exists on treatment in patients with CKD stages 2 to 3, where CKD progression might be slowed by HCV treatment. These patients are not considered a high priority for HCV treatment in most international guidelines. Although some recently published guidelines propose universal treatment, others are still recommending it only in high priority groups. In this review, we evaluate current evidence of HCV infection impact on CKD progression, on cardiovascular and metabolic risk, and the benefits of HCV infection treatment to improve cardiovascular and metabolic outcomes. We made special focus on the benefits of HCV infection treatment in patients with stages 2 to 3 CKD to avoid CKD progression.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
Wiley Blackwell Publishing, Inc
dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
CHRONIC KIDNEY DISEASE STAGES 2 TO 3
dc.subject
DIRECT-ACTING ANTIVIRAL AGENTS
dc.subject
HEPATITIS C VIRUS INFECTION
dc.subject
TREATMENT
dc.subject.classification
Gastroenterología y Hepatología
dc.subject.classification
Medicina Clínica
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
dc.title
Rationale for treating hepatitis C virus infection in patients with mild to moderate chronic kidney disease
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2019-10-09T20:45:45Z
dc.journal.volume
22
dc.journal.pagination
S97-S103
dc.journal.pais
Reino Unido
dc.journal.ciudad
Londres
dc.description.fil
Fil: Ridruejo, Ezequiel. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. CEMIC-CONICET. Centro de Educaciones Médicas e Investigaciones Clínicas "Norberto Quirno". CEMIC-CONICET; Argentina. Hospital Universitario Austral; Argentina. Latin American Liver Research, Educational and Awareness Network; Argentina
dc.description.fil
Fil: Mendizabal, Manuel. Hospital Universitario Austral; Argentina. Latin American Liver Research, Educational and Awareness Network; Argentina
dc.description.fil
Fil: Silva, Marcelo O.. Hospital Universitario Austral; Argentina. Latin American Liver Research, Educational and Awareness Network; Argentina
dc.journal.title
Hemodialysis International
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1111/hdi.12651
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/full/10.1111/hdi.12651
Archivos asociados